Brian Orelli

Brian Orelli

TMFBiologyFool

Dr. Orelli is a Senior Biotech Specialist. He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007.

Recent articles









ImmunoGen, Inc. Moves Forward

With lead program Forward I not scheduled to read out until 2019, investors have to be content with data from an earlier stage.